The calls will be open from 1 August to 2 September 2024. There are numerous awards granted by ESCMID in celebration of excellence and innovation in CM & ID:

• Excellence Award for Scientific Contributions in CM/ID
• Lifetime Achievement Award
• Award for Outstanding Contributions in the Field of Infection
• Young Investigator Award
• Emerging Young Investigator Award
• TAE Outstanding Trainee Award

Read more about past awardees to get inspiration.

Science & Research

Our Study Groups periodically organise web symposia featuring discussions, expert insights, and cutting-edge research in the fields of CM and ID.

Check on our website the list of recent and upcoming web symposia, as well as links to register or direct links to join the live events. Each symposium is recorded and made available in the ESCMID eLibrary following the event.

Education

The next module of the Adaptive Clinical Trial Designs course - Module 4: “Response adaptive randomisation and covariate -adjusted response adaptive randomisation designs” - will be available as of tomorrow, 31 July 2024. In this module, the speakers will introduce the theory behind response adaptive and covariate adjusted response adaptive randomisation designs and demonstrate the designs' benefits by presenting the case studies, end-TB and I-Spy 2 trials.

The call for 50 Funded Observerships will be open from 10 September to 16 October 2024. ESCMID Observerships provide participants with a fantastic opportunity to gain experience and exchange knowledge with colleagues across the fields of CM & ID. Choose and contact your target institution among 123 ESCMID Collaborative Centres, to get your endorsement letter stating purpose and dates of the Observership.

Dive into the forefront of phage therapy with this course, designed to illuminate the current clinical experiences, compassionate use protocols, cohort studies, and ongoing clinical trials in the field. Gain valuable insights into the establishment of phage therapy centres, navigating evolving global regulations.

Registration is open and ESCMID Attendance Grants are available!

Congress & Events

ESCMID is pleased to announce that MDPI and their open access journal antibiotics are sponsoring the best oral abstract presentation award. During the conference, the programme committee will follow and monitor all oral abstract presentations and decide on the winner of this award.

The award will be given during the closing session on the last conference day, 12:00 - 12:30 WEST on 20 September 2024. The awardee will be granted free registration to the next ESCMID conference.

Guidelines & Journals

In this episode of Communicable, “Sneaky viruses”: an update on hepatitis B & C, hosts Angela Huttner and Oana Sandulescu welcome special guest and leading hepatitis expert, Professor Mojca Matičič (Ljubljana, Slovenia), to refresh your knowledge on the pathogenesis of hepatitis B & C infections, review the latest direct-acting antiviral (DAA) therapies, map out some countries’ successful elimination initiatives, and understand challenges remaining for others.

In recognition of World Hepatitis Day on 28 July, the Communicable team urges our listeners to inform themselves and others, and to test, treat, and vaccinate against viral hepatitis.

Scientific misconduct in infectious diseases – European Society of Clinical Microbiology and Infectious Diseases (ESCMID) survey

Gut colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in vegetarians: A systematic review and meta-analysis